S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Electric Vehicles Can Drive Alcoa Stock Higher
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Electric Vehicles Can Drive Alcoa Stock Higher
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Electric Vehicles Can Drive Alcoa Stock Higher
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Electric Vehicles Can Drive Alcoa Stock Higher
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
NASDAQ:APM

Aptorum Group - APM Stock Forecast, Price & News

$1.54
-0.01 (-0.65%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$1.46
$1.62
50-Day Range
$1.11
$1.55
52-Week Range
$0.86
$2.94
Volume
112,100 shs
Average Volume
1.17 million shs
Market Capitalization
$54.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
APM stock logo

About Aptorum Group (NASDAQ:APM) Stock

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Aptorum Group Price Performance

NASDAQ:APM traded down $0.01 during trading hours on Friday, reaching $1.54. The stock had a trading volume of 112,117 shares, compared to its average volume of 118,050. The stock has a fifty day moving average of $1.34 and a 200 day moving average of $1.42. Aptorum Group has a 52-week low of $0.86 and a 52-week high of $2.94.

Receive APM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptorum Group and its competitors with MarketBeat's FREE daily newsletter.

APM Stock News Headlines

Aptorum Group Limited Interview to Air on Bloomberg U.S.
Aptorum To Start Testing SACT-1 In Neuroblastoma Patients
See More Headlines
Receive APM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptorum Group and its competitors with MarketBeat's FREE daily newsletter.

APM Company Calendar

Today
8/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APM
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.54 million
Book Value
$0.49 per share

Miscellaneous

Free Float
N/A
Market Cap
$54.89 million
Optionable
Not Optionable
Beta
0.07

Key Executives

  • Mr. Darren Lui (Age 40)
    CEO, Chief Accounting Officer & Exec. Director
    Comp: $323.33k
  • Dr. Clark Cheng (Age 42)
    Chief Medical Officer & Exec. Director
    Comp: $540.21k
  • Dr. Wai Yip Lee (Age 48)
    Head of R&D
    Comp: $474.12k
  • Mr. Martin Siu
    Head of Fin.













APM Stock - Frequently Asked Questions

How has Aptorum Group's stock price performed in 2022?

Aptorum Group's stock was trading at $1.50 on January 1st, 2022. Since then, APM shares have increased by 2.7% and is now trading at $1.54.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Aptorum Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptorum Group investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Micron Technology (MU), Sanofi (SNY) and Aridis Pharmaceuticals (ARDS).

What is Aptorum Group's stock symbol?

Aptorum Group trades on the NASDAQ under the ticker symbol "APM."

How do I buy shares of Aptorum Group?

Shares of APM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aptorum Group's stock price today?

One share of APM stock can currently be purchased for approximately $1.54.

How much money does Aptorum Group make?

Aptorum Group (NASDAQ:APM) has a market capitalization of $54.89 million and generates $1.54 million in revenue each year.

How many employees does Aptorum Group have?

Aptorum Group employs 25 workers across the globe.

How can I contact Aptorum Group?

Aptorum Group's mailing address is 17/F GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL, HONG KONG K3, 999077. The official website for Aptorum Group is www.aptorumgroup.com. The company can be reached via phone at 442080929299 or via email at investor.relations@aptorumgroup.com.

This page (NASDAQ:APM) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.